Delivery Order HHSN261201000004I-HHSN26100001
Award Date
1/26/10
Potential Completion Date
1/25/15
Potential Value
$509K
Federal Agency
National Cancer Institute
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
R499 - Support- Professional: Other
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chapel Hill, NC 27599, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the National Cancer Institute (NCI) to the University of North Carolina at Chapel Hill (UNC-CH) for $13,300 under the NCI Cancer Genome Atlas Program Tissue Purchase contract. The purpose is to obtain tissue samples and data from various cancer types to support the Cancer Genome Atlas (TCGA) program, which aims to characterize the genomic changes in different cancer types. The contract is a firm fixed-price delivery order with a completion date of March 31,...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, to Duke University for $270,900.00. The contract is part of the NCI's Cancer Genome Atlas (TCGA) program and is funded through the American Recovery and Reinvestment Act (ARRA). Under this contract, Duke University will provide tissue samples and data from various types of cancer to support the TCGA program. The contract does not have a...
This is a delivery order awarded to the University of North Carolina at Chapel Hill (UNC) under the NCI Genomic Characterization Centers indefinite delivery, indefinite quantity (IDIQ) contract. The order is for RNA sequencing services, with a period of performance from August 31, 2019 to August 30, 2020. The total ceiling value of this order is $4,385,896.69. The National Cancer Institute, a civilian agency within the Department of Health and Human Services, is the funding agency. UNC is a...
The National Cancer Institute (NCI) awarded a $1,498,043 Firm Fixed Price Delivery Order contract to the University of North Carolina at Chapel Hill (UNC-CH) for the Genome Characterization Center RNA Sequencing Indefinite Delivery/Indefinite Quantity (IDIQ) Contract. This multiple-award IDIQ contract enables UNC-CH to provide comprehensive genome sequencing and analysis capabilities, including high-throughput DNA sequencing, RNA sequencing, epigenetic characterization, and single-cell/nuclei...
This is a delivery order contract awarded under the NCI Cancer Genome Atlas Program Tissue Purchase indefinite delivery/indefinite quantity (IDIQ) contract. The contract was awarded by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services, for the recovery of tissue samples and data from various cancer types for the Cancer Genome Atlas (TCGA) program. This work is funded through the American Recovery and Reinvestment Act (ARRA). The contract was...
This is a firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), part of the Department of Health and Human Services (HHS), to the University of Pittsburgh for tissue samples and data from various cancer types to support the Cancer Genome Atlas (TCGA) program. The $285,310.98 contract was awarded on May 12, 2010 under the NCI Cancer Genome Atlas Program Tissue Purchase master IDIQ contract, with a period of performance through March 31, 2015. The contract does...
This is a $110,445.12 firm fixed-price delivery order contract awarded by the National Cancer Institute (NCI), which is part of the Department of Health and Human Services (HHS), to the University of Pittsburgh. The contract is for the recovery of tissue samples and data from various types of cancer to support the Cancer Genome Atlas (TCGA) program, which is part of the NCI's cancer research efforts. The contract has no set-aside designation, indicating it was competed openly. The University...
The University of North Carolina at Chapel Hill (UNC-CH) was awarded a $9,965,712.00 Other Transaction Agreement contract by the National Institutes of Health (NIH) for a project titled "CANCER SURVEILLANCE AND PRECISION HEALTH EQUITY". The contract has a period of performance through September 17, 2026. UNC-CH, as the prime contractor, will provide research and technical services to support NIH's mission in areas such as biomedical research, public health, and medical countermeasure...
This is a $142,143.34 firm fixed-price delivery order awarded by the National Cancer Institute (NCI) to the University of Pittsburgh for the NCI's Cancer Genome Atlas (TCGA) program. The contract is to provide tissue samples and data from various types of cancer to support the TCGA program, which aims to construct a comprehensive "atlas" of the molecular changes involved in human cancers. The award is not set aside and is part of a larger IDIQ contract titled the "NCI Cancer...
This is a $530,233.58 firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency under the U.S. Department of Health and Human Services, to the University of Pittsburgh. The contract supports the Cancer Genome Atlas (TCGA) program under the American Recovery and Reinvestment Act (ARRA), which aims to collect tissue samples and data from various cancer types. The contract does not have a set-aside designation. The University of Pittsburgh, a large...